Keyphrases
Alpha-fetoprotein
25%
Altered Anatomy
12%
Antiviral Prophylaxis
25%
Argon Plasma Coagulation
25%
Ascending Colon
25%
Billroth II Gastrectomy
25%
C-Jun
25%
Carcinoma in Situ
12%
Cervical Cancer
25%
Chemotherapy
25%
Chronic Radiation Proctitis
25%
Curative Treatment
16%
Cyclooxygenase-2
25%
Direct Extension
12%
Endoscopic Retrograde Cholangiopancreatography
25%
Gastric Cancer Patients
25%
Gastrointestinal Involvement
12%
Hematogenous Metastasis
12%
Hepatitis B Virus Reactivation
25%
Hepatocellular Carcinoma
73%
Hepatocellular Carcinoma Patients
21%
Hepatocellular Carcinoma Surveillance
25%
Histopathological Examination
12%
Hyperplastic Polyp
12%
Indonesia
28%
Indonesian
50%
Intermediate-stage Hepatocellular Carcinoma
25%
Lamivudine
25%
Malignant Biliary Obstruction
25%
Metastatic Cervical Cancer
25%
National Cancer Institute
25%
Nuclear factor-κB
25%
Obstructive Jaundice
12%
Pancreatic Ductal Adenocarcinoma
25%
Patient Survival
25%
Percutaneous Endoscopic Surgery
25%
Percutaneous Transhepatic Biliary Drainage
12%
Previous History
12%
Real-world Experience
25%
Real-world Practice
16%
Recto
12%
Rendezvous Technique
25%
Sessile Polyp
25%
Sorafenib
16%
Specificity Protein 1
25%
Systemic Therapy
25%
Telbivudine
25%
Transarterial Chemoembolization
25%
Treatment Options
13%
Worse Prognosis
12%
Medicine and Dentistry
Abdominal Cancer
25%
Adenocarcinoma
6%
Alpha-Fetoprotein
25%
Argon Plasma Coagulation
25%
Ascending Colon
25%
Atezolizumab
5%
Biliary Tract Drainage
12%
Billroth II
25%
Biological Marker
25%
Cabozantinib
5%
Cervical Cancer
25%
Cholestasis
25%
Chronic Liver Disease
5%
Clinical Decision Making
5%
Clinical Trial
5%
Clinician
5%
Digestive System Surgery
6%
Diseases
10%
Endoscopic Retrograde Cholangiopancreatography
25%
Health Care
10%
Hepatitis B
7%
Hepatocellular Carcinoma
100%
Immune Checkpoint Inhibitor
5%
Immunohistochemistry
6%
Lenvatinib
5%
Liver Cancer
5%
Liver Cirrhosis
5%
Liver Function
5%
Malignant Neoplasm
48%
Metastatic Carcinoma
6%
Monoclonal Antibody
5%
Nuclear Factor
25%
Obstructive Jaundice
12%
Pancreas Adenocarcinoma
25%
Patient Characteristics
5%
Polyp
25%
Prevalence
6%
Prognostic Factor
5%
Radiation Proctitis
25%
Ramucirumab
5%
Regorafenib
5%
Sensitivity and Specificity
5%
Sigmoid
6%
Sorafenib
10%
Systemic Therapy
25%
Transcatheter Arterial Chemoembolization
17%
Transcription Factor Sp1
25%
Tumor Biology
5%
Tumor Marker
5%
Vasculotropin
5%
Pharmacology, Toxicology and Pharmaceutical Science
Adenocarcinoma
6%
Alpha Fetoprotein
25%
Antivirus Agent
25%
Ascending Colon
25%
Atezolizumab
5%
Bevacizumab
5%
Biological Marker
25%
Cabozantinib
5%
Chemotherapy
25%
Chronic Liver Disease
5%
Clinical Feature
6%
Clinical Trial
5%
Diseases
15%
Hepatitis B
32%
Hepatitis B Antigen
8%
Hepatitis B Core Antibody
5%
Hepatitis B Virus
8%
Immune Checkpoint Inhibitor
5%
Lamivudine
25%
Lenvatinib
5%
Liver Cancer
5%
Liver Cell Carcinoma
100%
Liver Cirrhosis
5%
Malignant Neoplasm
42%
Monoclonal Antibody
5%
Neoplasm
5%
Nuclear Factor
25%
Pancreas Adenocarcinoma
25%
Polyp
25%
Proctitis
25%
Ramucirumab
5%
Rectum Hemorrhage
6%
Regorafenib
5%
Sorafenib
10%
Telangiectasia
6%
Telbivudine
25%
Transcription Factor Sp1
25%
Tumor Marker
5%
Ulcer
6%
Uterine Cervix Cancer
25%
Vasculotropin
5%